The Effect of Neoadjuvant Chemotherapy on Breast Cancer-Related Lymphedema: A Prospective Clinical Trial

Background: Breast cancer-related lymphedema (BCRL) is a frequent complication that can impair the quality of life of survivors. While the effect of surgery and radiotherapy on lymphedema has been well established, the independent impact of neoadjuvant chemotherapy (NACT) on extracellular fluid remains unclear. Methods: In this prospective clinical study, 111 patients with breast cancer scheduled for NACT were evaluated before and after chemotherapy. Arm circumferences and bioimpedance spectroscopy (BIS, L-Dex U400 ® ) were performed pre- and post-NACT to assess extracellular fluid changes. A ≥6.5-unit increase in L-Dex was considered significant. Demographic, clinical, and pathological variables were analyzed using univariate and multivariate logistic regression. Results: Extracellular fluid increase was detected in 18 patients (16.2%) after NACT, with no clinical lymphedema observed. In multivariate analysis, age ≥55 years (OR 4.47, 95% CI: 1.35–14.89; p = 0.015) and higher clinical N stage (OR 2.26, 95% CI: 1.16–4.43; p = 0.017) were independent predictors of extracellular fluid increase, whereas hormone receptor positivity was protective (OR 0.23, 95% CI: 0.07–0.72; p = 0.012). Conclusions: NACT may contribute to subclinical extracellular fluid accumulation, particularly in older patients, those with advanced nodal disease, and those lacking hormone receptor positivity. Early BIS monitoring during chemotherapy may facilitate the detection of subclinical extracellular fluid changes and identify patients who may warrant closer surveillance for subsequent lymphedema.

Authors

Institutions

Publication Details

Journal
Lymphatic Research and Biology
Published
2026-11-12
DOI
https://doi.org/10.1177/15578585261506072
Primary Topic
Lymphatic System and Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The Effect of Neoadjuvant Chemotherapy on Breast Cancer-Related Lymphedema: A Prospective Clinical Trial

Vahit Özmen, Zeynep Erdoğan İyigün, Ertan Koç, Enver Özkurt et al.
Lymphatic Research and Biology
Lymphatic System and Diseases
article

The Effect of Neoadjuvant Chemotherapy on Breast Cancer-Related Lymphedema: A Prospective Clinical Trial

Vahit Özmen, Zeynep Erdoğan İyigün, Ertan Koç, Enver Özkurt, Tuğba Akın Telli, Gürsel Soybir, Ceren Hafızoğlu
article en

Abstract

Background: Breast cancer-related lymphedema (BCRL) is a frequent complication that can impair the quality of life of survivors. While the effect of surgery and radiotherapy on lymphedema has been well established, the independent impact of neoadjuvant chemotherapy (NACT) on extracellular fluid remains unclear. Methods: In this prospective clinical study, 111 patients with breast cancer scheduled for NACT were evaluated before and after chemotherapy. Arm circumferences and bioimpedance spectroscopy (BIS, L-Dex U400 ® ) were performed pre- and post-NACT to assess extracellular fluid changes. A ≥6.5-unit increase in L-Dex was considered significant. Demographic, clinical, and pathological variables were analyzed using univariate and multivariate logistic regression. Results: Extracellular fluid increase was detected in 18 patients (16.2%) after NACT, with no clinical lymphedema observed. In multivariate analysis, age ≥55 years (OR 4.47, 95% CI: 1.35–14.89; p = 0.015) and higher clinical N stage (OR 2.26, 95% CI: 1.16–4.43; p = 0.017) were independent predictors of extracellular fluid increase, whereas hormone receptor positivity was protective (OR 0.23, 95% CI: 0.07–0.72; p = 0.012). Conclusions: NACT may contribute to subclinical extracellular fluid accumulation, particularly in older patients, those with advanced nodal disease, and those lacking hormone receptor positivity. Early BIS monitoring during chemotherapy may facilitate the detection of subclinical extracellular fluid changes and identify patients who may warrant closer surveillance for subsequent lymphedema.

Lymphatic Research and Biology
Bahçeşehir University (TR), Istanbul Florence Nightingale Hospital (TR), Memorial Sisli Hospital (TR)
Lymphatic System and Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon